22 May 2013
Keywords: bayer, precose, launched, its, oral, alpha, glucosidase
Article | 08 January 1996
- Bayer has launched its oral alpha glucosidase inhibitor Precose
(acarbose) in the USA for the treatment of type II diabetes. ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
15 January 1996
8 January 1996
21 May 2013
© 2013 thepharmaletter.com